Determinants of costs of care for patients with Alzheimer's disease

  title={Determinants of costs of care for patients with Alzheimer's disease},
  author={Linus J{\"o}nsson and Maria Eriksdotter J{\"o}nhagen and Lena Kilander and Hilkka Soininen and Merja Hallikainen and Gunhild Waldemar and Harald A. Nygaard and Niels Andreasen and Bengt Winblad and Anders Wimo},
  journal={International Journal of Geriatric Psychiatry},
Alzheimer's disease (AD), the most common cause of dementia, is a major cause of disability and care burden in the elderly. This study aims to estimate the costs of formal and informal care and identity determinants of care costs. 
The Effects of Patient Function and Dependence on Costs of Care in Alzheimer's Disease
OBJECTIVES: To estimate incremental effects of patients' dependence and function on costs of care during the early stages of Alzheimer's disease (AD) and to compare strengths of their relationships
The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland
To explore the incremental effects of patient dependence and function on costs of care for patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI) in Ireland, a large number of patients with AD and MCI have had no contact with the NHS.
Patients with Lewy body dementia use more resources than those with Alzheimer's disease
The purpose of this study was to compare resource use and costs in patients with dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) and to assess determinants of costs of care in DLB.
Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias
To assess changes in behavioral symptoms associated with Alzheimer's disease and related dementias (ADRDs) after antipsychotic (AP) or antidepressant (AD) treatment and to estimate the effect of
Costs of care in a mild-to-moderate Alzheimer clinical trial sample: Key resources and their determinants
The worldwide economic impact of dementia 2010
The main cost drivers in dementia: a systematic review
Because of the increasing prevalence of dementia worldwide, combined with limited healthcare expenditures, a better understanding of the main cost drivers of dementia in different care settings is
Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework


Cost of Alzheimer's Disease and Related Dementia in Managed‐Medicare
A large number of MCOs will have increased responsibility for the care of large numbers of persons with dementia, but there are few studies that inform about decisions of healthcare utilization and expenditures for individuals with dementia in managed care.
How Much Do Persons with Alzheimer's Disease Cost Medicare?
Past work has been limited by the use of only 1 or 2 years of claims data to identify cases, leading to worries that this might lead to an undercount of prevalent cases and bias cost findings.
The economic burden of Alzheimer's disease care.
With projected increases in the number of persons at risk of developing Alzheimer's disease, the economic impact of the disease on future long-term care costs will be significant.
Cost of illness due to dementia in Sweden
The gross cost of illness due to dementia was estimated to be SEK30.7 billion in 1991 while the net cost was estimated to be SEK20 billion. The sensitivity analysis showed a variation between SEK20
The relative effect of Alzheimer's disease and related dementias, disability, and comorbidities on cost of care for elderly persons.
Disability measured by ADL limitations was a more important predictor of total cost than was ADRD status in both stratified and multivariate analyses, and comorbidities such as heart attack, stroke, and chronic obstructive pulmonary disease also increased costs.
Relation between severity of Alzheimer's disease and costs of caring.
The societal cost of care of Alzheimer's disease increases drastically with increasing disease severity, and institutionalization was the largest component of cost, accounting for as much as 84% of the cost for people with severe disease.
The cost of Alzheimer's disease in managed care: a cross-sectional study.
The cost of care of community-dwelling AD patients receiving care through a health maintenance organization (HMO) system in the United States is focused on, with a total annual cost of $8.8 billion for managed care enrollees older than 65 years.
An Economic Perspective on Alzheimer's Disease
  • M. Trabucchi
  • Medicine
    Journal of geriatric psychiatry and neurology
  • 1999
The results of studies on a number of interventions, namely, screening, reality orien tation therapy, special care units, family interventions, and drug treatment, are discussed, although the costs and the long-term benefits associated with many of these remain unknown.
Economic impact of Alzheimer's disease in the United Kingdom
The cost of care for an Alzheimer's disease patient is directly related to the severity of the patient's illness.
Estimating the relationship between disease progression and cost of care in dementia
Background Previous studies have shown a positive relationship between disease severity and cost. Aims To explore the factors affecting time to institutionalisation and estimate the relationship